Dapagliflozin improves treatment satisfaction in overweight patients with type 2 diabetes mellitus: a patient reported outcome study (PRO study)

被引:0
|
作者
Hiroki Nakajima
Sadanori Okada
Takako Mohri
Eiichiro Kanda
Naoyuki Inaba
Yoko Hirasawa
Hiroaki Seino
Hisamoto Kuroda
Toru Hiyoshi
Tetsuji Niiya
Hitoshi Ishii
机构
[1] Nara Medical University,Department of Diabetology
[2] Tokyo Kyosai Hospital,Department of Nephrology
[3] Tokyo Medical and Dental University,Life Science and Bioethics Research Center
[4] Shizuoka Saiseikai General Hospital,Department of Metabolism & Endocrinology
[5] Plumeria DM Clinic,Department of Internal Medicine
[6] Seino Internal Medicine Clinic,undefined
[7] Green Clinic,undefined
[8] Japanese Red Cross Medical Center,undefined
[9] Matsuyama Shimin Hospital,undefined
关键词
Type 2 diabetes mellitus; Oral hypoglycemic agent; Sodium glucose cotransporters 2 inhibitors; SGLT2 inhibitors; Dapagliflozin; Treatment satisfaction; Oral Hypoglycemic Agent-Questionnaire; Body weight; Patient reported outcome; Quality of life;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
相关论文
共 50 条
  • [41] PANORAMA: A European study to evaluate quality of life and treatment satisfaction in patients with type-2 diabetes mellitus-Study design
    Bradley, Clare
    de Pablos-Velasco, Pedro
    Parhofer, Klaus G.
    Eschwege, Eveline
    Goender-Frederick, Linda
    Simon, Dominique
    PRIMARY CARE DIABETES, 2011, 5 (04) : 231 - 239
  • [42] Dapagliflozin Effects on the Lipid Profile of Patients With Type 2 Diabetes Mellitus
    Hardy, Elise
    Ptaszynska, Agata
    De Bruin, Tjerk W. A.
    Johnsson, Eva
    Parikh, Shamik J.
    List, James F.
    DIABETES, 2013, 62 : A310 - A310
  • [43] Effect of dapagliflozin on arterial stiffness in patients with type 2 diabetes mellitus
    Hidalgo Santiago, Juan Carlos
    Maraver Delgado, Juan
    Cayon Blanco, Manuel
    Lopez Saez, Juan Bosco
    Gomez-Fernandez, Pablo
    MEDICINA CLINICA, 2020, 154 (05): : 171 - 174
  • [44] Semaglutide 2.4 mg Improves Patient Reported Outcome Measures of Physical Functioning in Adults with Overweight/Obesity and Type 2 Diabetes in the STEP 2 Trial
    Wharton, Sean
    Meincke, Henrik H.
    Kushner, Robert F.
    Oral, Tugce Kalayci
    Pedersen, Sue
    Rubino, Domenica
    Ryan, Donna H.
    Zeuthen, Niels
    Kolotkin, Ronette
    DIABETES, 2021, 70
  • [45] Effect of dapagliflozin on the serum metabolome in patients with type 2 diabetes mellitus
    Filippas-Ntekouan, Sempastian
    Dimou, Aikaterini
    Dafopoulos, Panagiotis
    Kostara, Christina
    Bairaktari, Eleni
    Chasapi, Styliani
    Spyroulias, Georgios
    Koufakis, Theoharis
    Koutsovasilis, Anastasios
    Tsimihodimos, Vasileios
    JOURNAL OF DIABETES AND METABOLIC DISORDERS, 2024, 24 (01)
  • [46] DAPAGLIFLOZIN IMPROVES GLYCAEMIC CONTROL AND REDUCES BODY WEIGHT ACROSS VARIOUS PATIENT POPULATIONS WITH TYPE 2 DIABETES MELLITUS
    Ptaszynska, Agata
    Parikh, Shamik
    Hardy, Elise
    Wei, Li
    Wessman, Catrin
    INTERNAL MEDICINE JOURNAL, 2013, 43 : 49 - 49
  • [47] Patient-reported outcomes among patients with type 2 diabetes mellitus treated with dapagliflozin in a triple-therapy regimen for 52 weeks
    Grandy, S.
    Sternhufvud, C.
    Ryden, A.
    Sugg, J.
    Rohwedder, K.
    DIABETES OBESITY & METABOLISM, 2016, 18 (03): : 306 - 309
  • [48] Dapagliflozin improves glycaemic control and reduces body weight across various patient populations with type 2 diabetes mellitus
    Parikh, S.
    Hardy, E.
    Wei, L.
    Wessman, C.
    Salsali, A.
    Ptaszynska, A.
    DIABETOLOGIA, 2012, 55 : S305 - S305
  • [49] Development of an instrument for patient-reported outcomes in Thai patients with type 2 diabetes mellitus (PRO-DM-Thai)
    Chuayruang, Kanisshanone
    Sriratanaban, Jiruth
    Hiransuthikul, Narin
    Suwanwalaikorn, Sompongse
    ASIAN BIOMEDICINE, 2015, 9 (01) : 7 - 19
  • [50] Patient Self-reported Quality of Life Assessment in Type 2 Diabetes Mellitus: A Pilot Study
    PrasannaKumar, H. R.
    Mahesh, M. G.
    Menon, V. B.
    Srinath, K. M.
    Shashidhara, K. C.
    Ashok, P.
    NIGERIAN JOURNAL OF CLINICAL PRACTICE, 2018, 21 (03) : 343 - 349